Company intelligence / Profile preview

Lo.Li. Pharma International

Rome, Latium, Italy

Ownership: Private
Employees: ~101
Development stage: Other

Overview

Lo.Li. Pharma International markets over 35 clinically tested dietary supplements and medical devices, with leading products for infertility, PCOS, persistent HPV, and other conditions, used globally and supported by clinical studies.

Therapeutic areas: EndocrinologyPsychiatryMen's HealthInfectious DiseasesPulmonologyWomen's Health
Modalities: Small moleculeMedical device
Industry: Food & Nutrition

Beyond the preview

Go deeper on Lo.Li. Pharma International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lo.Li. Pharma International.

Explore the full profile